Drug Delivery Executive: Dr. Joseph Mo, President and CEO of NexMed, explains how his company’s transdermal drug delivery system has been incorporated with existing drugs to develop new patient-friendly transdermal products, thereby extending patent lifespan and brand equity.

View Full Article